Discovery STREAM
-
The NanoAssemblr® Spark™ Robust Low Volume RNA-Lipid Nanoparticle Formulation
4/14/2022
Develop RNA-lipid nanoparticles (LNPs) in under 10 seconds for drug discovery and early preclinical development. The NanoAssemblr®️ Spark™ instrument enables rapid µL formulations to conserve limited and expensive ingredients with minimal waste.
-
GLP And The Impact To Start Up Companies
4/18/2022
Good Laboratory Practice is often used in laboratories and is necessary for specific investigations. What does it mean? And how can it help start-up companies? Watch this video to learn more.
-
Meet Your Bioprocess Sidekick For Cell Culture Media Analysis
6/10/2022
You need rapid and reliable nutrient profiles to make informed decisions, and waiting on that data has detrimental effects on your process. See how REBEL fills the gap.
-
An All-In-One Solution For Residual DNA Quantitation
5/22/2025
Explore an all-in-one solution for residual DNA quantitation with a 3D lab tour with virtual demos, videos, and interactive instrument guides to experience the full workflow.
-
Streamline Your mRNA Purification Steps
3/4/2025
Ensure your mRNA's stability and effectiveness post-transcription with advanced filtration and chromatography techniques to enhance purity and recovery, which delivers high-quality mRNA for superior therapeutics and vaccines.
-
Can Kinetics Provide Detailed Information About Binding Interactions?
2/17/2022
See the potential value kinetics brings to deepen the understanding of biological processes.
-
How J&J Is Tackling Alzheimer's Disease With Fiona Elwood, Ph.D.
9/22/2025
Fiona Elwood, Ph.D., VP and Neurodegeneration Disease Area Stronghold Leader at Johnson & Johnson, explains the company’s modality-agnostic approach to treating Alzheimer’s disease in this episode of Better Biopharma.
-
Can You Run Crude Samples Using An SPR Instrument?
2/17/2022
We explore a common misconception and provide examples of complex material being used in an SPR system.
-
Testing Liquid Handler Performance With PCRMix
5/6/2022
We demonstrate the importance of using an appropriate test solution when optimizing a liquid handler to dispense the master mix, a critical component in any PCR-based assay.
-
Don't Be A D**k With Ochre Bio's Dr. Quin Wills
9/27/2023
Don't be offended by the title of today's Business of Biotech podcast. Dr. Quin Wills' application of what's become known as "Wheaton's Law" (look it up) is central to the ambitious goals his company, Ochre Bio, is pursuing: pioneering the value of computational biology in large mol discovery and development, putting an end to the global liver disease epidemic, and changing the costly, high-risk approach to clinical trials. On this week's episode, Dr. Wills and I explore how those goals are being addressed despite the challenges they present, and how the company's three guiding principles, don't be a d**k being one of them, align the Ochre team with the mission at hand.